Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (501-510 of 768) with videos related to

Pageof 77
Sort By:
Transplantation and Cellular Therapy|July 27, 2025
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell TransplantsRima M Saliba, Matthias Niemann, Samer A Srour, et al.
Journal of Blood Medicine|January 28, 2012
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomasChitra Hosing, Mark F Munsell, James M Reuben, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2016
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic LeukemiaSamer A Srour, Denái R Milton, Asad Bashey, et al.
Leukemia & Lymphoma|August 24, 2011
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary resultsPaolo Anderlini, Rima M Saliba, Celina Ledesma, et al.
Pediatric Transplantation|February 5, 2017
Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experienceOssama M Maher, Jorge Galvez Silva, Jimin Wu, et al.
Haematologica|February 29, 2020
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantationRima M Saliba, Lauren Veltri, Gabriela Rondon, et al.
British Journal of Haematology|June 20, 2008
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantationAmin M Alousi, Rima M Saliba, Grace-Julia Okoroji, et al.
Blood|January 27, 2009
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphomaConstantine S Tam, Roland Bassett, Celina Ledesma, et al.
Transplantation and Cellular Therapy|September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative ConditioningJacinth Joseph, Samer A Srour, Denái R Milton, et al.
Leukemia|February 28, 2015
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myelomaN Shah, P F Thall, P S Fox, et al.
Pageof 77

Showing results (501-510 of 768) with videos related to

Sort By:
Pageof 77
Transplantation and Cellular Therapy|July 27, 2025
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell TransplantsRima M Saliba, Matthias Niemann, Samer A Srour, et al.
Journal of Blood Medicine|January 28, 2012
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomasChitra Hosing, Mark F Munsell, James M Reuben, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 19, 2016
Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic LeukemiaSamer A Srour, Denái R Milton, Asad Bashey, et al.
Leukemia & Lymphoma|August 24, 2011
Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem cell transplant in relapsed and refractory Hodgkin lymphoma: preliminary resultsPaolo Anderlini, Rima M Saliba, Celina Ledesma, et al.
Pediatric Transplantation|February 5, 2017
Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-The MD Anderson Cancer Center experienceOssama M Maher, Jorge Galvez Silva, Jimin Wu, et al.
Haematologica|February 29, 2020
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantationRima M Saliba, Lauren Veltri, Gabriela Rondon, et al.
British Journal of Haematology|June 20, 2008
Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-cell lymphoma treated with autologous stem cell transplantationAmin M Alousi, Rima M Saliba, Grace-Julia Okoroji, et al.
Blood|January 27, 2009
Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphomaConstantine S Tam, Roland Bassett, Celina Ledesma, et al.
Transplantation and Cellular Therapy|September 24, 2023
Transplantation Outcomes of Myelofibrosis with Busulfan and Fludarabine Myeloablative ConditioningJacinth Joseph, Samer A Srour, Denái R Milton, et al.
Leukemia|February 28, 2015
Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myelomaN Shah, P F Thall, P S Fox, et al.
Pageof 77